Health Condition 1: M058- Other rheumatoid arthritis with rheumatoid factor
Conditions
Interventions
Intervention1: Amirdha Gandhi Kukil Vallathy (AGKV).: Dose: 2 gm twice a day after food
Vehicle : warm water
Duration: 48 days
Intervention2: Not applicable: It is a single arm study so Comparator
Sponsors
None listed
Eligibility
Inclusion criteria
Inclusion criteria: EULAR score >6 Patients willing to give informed consent Pt having score more than 6 are considered to have RA
Exclusion criteria
Exclusion criteria: Pregnancy and lactation Patients taking DMRAD s like Methotrexate Patients who had already participated in a new drug study in the past 3 months Known c/o Diabetes Mellitus Systemic Hypertension (SHT) Renal disease Cardiac disease Liver disorders Psoriatic arthritis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Response to treatment â?? Reduction in EULAR score from baseline to end of the studyTimepoint: Response to treatment â?? Reduction in EULAR score from baseline to end of the study | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction in clinical signs and symptoms by Decrease in Rheumatoid Arthritis Pain Scale (RAPS), Improvement in the quality of life by Modified health assessment questionnaire (MHAQ) will be assessedTimepoint: 48 days | — |
Countries
India
Contacts
Public ContactDr CHRISTIAN L
CENTRAL COUNCIL FOR RESEARCH IN SIDDHA, MINISTRY OF AYUSH
Outcome results
None listed